{"id":501666,"date":"2021-06-08T07:12:48","date_gmt":"2021-06-08T11:12:48","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\/"},"modified":"2021-06-08T07:12:48","modified_gmt":"2021-06-08T11:12:48","slug":"independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\/","title":{"rendered":"Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nFor questions or voting your shares, please contact Laurel Hill Advisory Group at 1-877-452-7184 or by email at <a rel=\"nofollow\" href=\"mailto:assistance@laurelhill.com\">assistance@laurelhill.com<\/a><\/li>\n<\/ul>\n<p>DARTMOUTH, Nova Scotia&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nIMV Inc. (\u201cIMV\u201d or the \u201cCorporation\u201d) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, will hold its 2021 annual and special meeting of shareholders (the &#8220;Meeting&#8221;) by way of a Virtual only meeting on Friday, June 18, 2021 at 11:00 am Eastern Daylight Time\n<\/p>\n<p>\nWe are pleased to announce that the two leading independent proxy advisory firms that provide voting recommendations to institutional investors, Institutional Shareholder Services Inc. (\u201cISS\u201d) and Glass Lewis &amp; Co. (\u201cGlass Lewis\u201d), have each recommended shareholders vote:\n<\/p>\n<p class=\"bwalignc\">\n\u25a0 <b>FOR<\/b> All Director Nominees\n<\/p>\n<p>\nIMV also wishes to note we have made an amendment to our Stock Option Plan. This amendment can be found on our website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.imv-inc.com&amp;esheet=52441774&amp;newsitemid=20210608005359&amp;lan=en-US&amp;anchor=www.imv-inc.com&amp;index=1&amp;md5=fe9ea806f5158db31f4b5f0e7c3a7b46\">www.imv-inc.com<\/a><\/p>\n<p>\nThe amendment restricts the maximum number of the Corporation\u2019s shares that may be subject to awards under the Stock Option Plan to 8%.\n<\/p>\n<p>\nShareholders can vote in advance of the meeting by mail, facsimile, email or internet in the manner set out in the meeting materials that have been sent to shareholders, copies of which can be accessed at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.envisionreports.com%2FIMV2021&amp;esheet=52441774&amp;newsitemid=20210608005359&amp;lan=en-US&amp;anchor=www.envisionreports.com%2FIMV2021&amp;index=2&amp;md5=5529e05615dc805cf3a0568fa16dd0dd\">www.envisionreports.com\/IMV2021<\/a>, on SEDAR at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedar.com&amp;esheet=52441774&amp;newsitemid=20210608005359&amp;lan=en-US&amp;anchor=www.sedar.com&amp;index=3&amp;md5=b8aef0ce81237ec74256d08682a9c8bd\">www.sedar.com<\/a> and on EDGAR at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov.&amp;esheet=52441774&amp;newsitemid=20210608005359&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=4&amp;md5=13514eef3bf25ef1e7ea92d77e54907e\">www.sec.gov<\/a><\/p>\n<p class=\"bwalignc\"><b>Your vote is important \u2013 Please Vote Today<\/b><\/p>\n<p class=\"bwalignc\"><b>The Board of Directors recommends that Shareholders vote FOR ALL resolutions.<\/b><\/p>\n<p class=\"bwalignc\"><b>Submit your vote well in advance of the proxy deposit deadline of June 16, 2021 at 11:00 am (Eastern Time)<\/b><\/p>\n<p>\nShareholders who have questions or require voting assistance may contact IMV\u2019s proxy solicitation agent, Laurel Hill Advisory Group, toll free in North America at 1-877-452-7184 (416-304-0211 outside North America) or by email at <a rel=\"nofollow\" href=\"mailto:assistance@laurelhill.com\">assistance@laurelhill.com<\/a><\/p>\n<p><b>IMV Forward-Looking Statements<\/b><\/p>\n<p>\nThis press release contains forward-looking information under applicable securities law. All information that addresses activities or developments that we expect to occur in the future is forward-looking information. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to, statements regarding the FDA potentially granting accelerated regulatory approval of maveropepimut-S and the timing of expected results from other maveropepimut-S\u2019s studies with other tumor types. However, they should not be regarded as a representation that any of the plans will be achieved. Actual results may differ materially from those set forth in this press release due to risks affecting the Corporation, including access to capital, the successful design and completion of clinical trials and the receipt and timely receipt of all regulatory approvals. IMV Inc. assumes no responsibility to update forward-looking statements in this press release except as required by law. These forward-looking statements involve known and unknown risks and uncertainties and those risks and uncertainties include, but are not limited to, our ability to access capital, the successful and timely completion of clinical trials and studies, the receipt of all regulatory approvals and other risks detailed from time to time in our ongoing quarterly filings and annual information form Investors are cautioned not to rely on these forward-looking statements and are encouraged to read IMV\u2019s continuous disclosure documents, including its current annual information form, as well as its audited annual consolidated financial statements which are available on SEDAR at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedar.com&amp;esheet=52441774&amp;newsitemid=20210608005359&amp;lan=en-US&amp;anchor=www.sedar.com&amp;index=5&amp;md5=9889388f2449813028d6cf478db86d6d\">www.sedar.com<\/a> and on EDGAR at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov%2Fedgar&amp;esheet=52441774&amp;newsitemid=20210608005359&amp;lan=en-US&amp;anchor=www.sec.gov%2Fedgar&amp;index=6&amp;md5=006514533088300e9844c6ccce1ad48f\">www.sec.gov\/edgar<\/a><\/p>\n<p><b>About IMV<\/b><\/p>\n<p>\nIMV Inc. is a clinical stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. IMV is pioneering a new class of cancer immunotherapies and vaccines against infectious diseases based on the Company\u2019s proprietary drug delivery platform, DPX. This patented technology leverages a novel mechanism of action that enables the programming of immune cells <i>in vivo,<\/i> which are aimed at generating powerful new synthetic therapeutic capabilities. IMV\u2019s lead candidate, maveropepimut-S, is a T cell-activating immunotherapy that combines the utility of the platform with a target: survivin. IMV is currently assessing maveropepimut-S as a monotherapy in advanced ovarian cancer, as well as a combination therapy in multiple clinical studies with Merck. Visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.imv-inc.com%2F&amp;esheet=52441774&amp;newsitemid=20210608005359&amp;lan=en-US&amp;anchor=www.imv-inc.com&amp;index=7&amp;md5=e6f05f93c0d7a3882d4b4d72b85ff867\">www.imv-inc.com<\/a> and connect with us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fimv_inc&amp;esheet=52441774&amp;newsitemid=20210608005359&amp;lan=en-US&amp;anchor=Twitter&amp;index=8&amp;md5=063b2283301013d0e637499cf4825826\">Twitter<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fimv-inc&amp;esheet=52441774&amp;newsitemid=20210608005359&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=9&amp;md5=402eefe8e0a2c598fd8de734c9920dc1\">LinkedIn<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005359r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210608005359\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210608005359\/en\/<\/a><\/span><\/p>\n<p><b>Investor Relations<br \/>\n<br \/>Marc Jasmin, Senior Director, Investor Relations, IMV<br \/>\n<br \/><\/b>O: (902) 492-1819, ext: 1042<br \/>\n<br \/>M: (514) 617-9481<br \/>\n<br \/>E: <a rel=\"nofollow\" href=\"mailto:mjasmin@imv-inc.com\">mjasmin@imv-inc.com<\/a><\/p>\n<p><b>Irina Koffler, Managing Director, LifeSci Advisors<br \/>\n<br \/><\/b>O: (646) 970-4681M: (917) 734-7387<br \/>\n<br \/>E: <a rel=\"nofollow\" href=\"mailto:ikoffler@lifesciadvisors.com\">ikoffler@lifesciadvisors.com<\/a><\/p>\n<p><b>Media<br \/>\n<br \/>Delphine Davan, Senior Director Communications, IMV<br \/>\n<br \/><\/b>M: (514) 968-1046<br \/>\n<br \/>E: <a rel=\"nofollow\" href=\"mailto:ddavan@imv-inc.com\">ddavan@imv-inc.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> North America Canada<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health Other Science General Health Research Science Pharmaceutical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210608005359\/en\/883581\/3\/IMV_Logos_IMV-Logo_Primary.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting For questions or voting your shares, please contact Laurel Hill Advisory Group at 1-877-452-7184 or by email at assistance@laurelhill.com DARTMOUTH, Nova Scotia&#8211;(BUSINESS WIRE)&#8211; IMV Inc. (\u201cIMV\u201d or the \u201cCorporation\u201d) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, will hold its 2021 annual and special meeting of shareholders (the &#8220;Meeting&#8221;) by way of a Virtual only meeting on Friday, June 18, 2021 at 11:00 am Eastern Daylight Time We are pleased to announce that the two leading independent proxy advisory firms that provide voting recommendations to institutional investors, Institutional &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-501666","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting For questions or voting your shares, please contact Laurel Hill Advisory Group at 1-877-452-7184 or by email at assistance@laurelhill.com DARTMOUTH, Nova Scotia&#8211;(BUSINESS WIRE)&#8211; IMV Inc. (\u201cIMV\u201d or the \u201cCorporation\u201d) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, will hold its 2021 annual and special meeting of shareholders (the &#8220;Meeting&#8221;) by way of a Virtual only meeting on Friday, June 18, 2021 at 11:00 am Eastern Daylight Time We are pleased to announce that the two leading independent proxy advisory firms that provide voting recommendations to institutional investors, Institutional &hellip; Continue reading &quot;Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-08T11:12:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005359r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting\",\"datePublished\":\"2021-06-08T11:12:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\\\/\"},\"wordCount\":830,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210608005359r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\\\/\",\"name\":\"Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210608005359r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-06-08T11:12:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210608005359r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210608005359r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting - Market Newsdesk","og_description":"Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting For questions or voting your shares, please contact Laurel Hill Advisory Group at 1-877-452-7184 or by email at assistance@laurelhill.com DARTMOUTH, Nova Scotia&#8211;(BUSINESS WIRE)&#8211; IMV Inc. (\u201cIMV\u201d or the \u201cCorporation\u201d) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, will hold its 2021 annual and special meeting of shareholders (the &#8220;Meeting&#8221;) by way of a Virtual only meeting on Friday, June 18, 2021 at 11:00 am Eastern Daylight Time We are pleased to announce that the two leading independent proxy advisory firms that provide voting recommendations to institutional investors, Institutional &hellip; Continue reading \"Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-08T11:12:48+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005359r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting","datePublished":"2021-06-08T11:12:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\/"},"wordCount":830,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005359r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\/","name":"Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005359r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-06-08T11:12:48+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005359r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005359r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/independent-proxy-advisory-firms-recommend-imv-shareholders-vote-for-all-director-nominees-at-the-upcoming-annual-general-and-special-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/501666","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=501666"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/501666\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=501666"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=501666"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=501666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}